New York, NY -- (SBWIRE) -- 02/22/2018 -- Description:
The analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020.
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.
The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions.
Get a Sample Report @ https://www.wiseguyreports.com/sample-request/533585-global-human-albumin-market-2016-2020
For more information or any query mail at sales@wiseguyreports.com
Covered in this report
The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
The report, Global Human Albumin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- CSL Behring
- Grifols
- Baxalta
- Octapharma
- Kedrion
Other prominent vendors
- AADi
- Ablynx
- Albumedix
- Ampio Pharmaceuticals
- Azaya Therapeutics
- Beijing Tiantan
- Biotest
- Bristol-Myers Squibb
- Celgene
- ConjuChem
- GSK
- Hebei Changshan Biochem Pharma
- HiMedia Laboratories
- Hualan Biological Engineering
- InVittria
- MedxBio
- Merck
- Mitsubishi Tanabe Pharma
- NantBioScience
- Novo Nordisk
- Novozymes
- Shanghai RAAS Blood Products
- Sucampo Pharmaceuticals
- Teva Pharmaceuticals
- Thermo Fisher Scientific
- Tianjin SinoBiotech & Beijing Bio-Fortune
- Ventria Bioscience
- Yoshitomi Pharmaceutical
Market driver
- High demand for human albumin in China
- For a full, detailed list, view our report
Market challenge
- Spread of pathogenic contaminants
- For a full, detailed list, view our report
Market trend
- Rise in non-therapeutic applications
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Report Details @ https://www.wiseguyreports.com/reports/533585-global-human-albumin-market-2016-2020
Table Of Contents – Major Key Points
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Plasma therapeutics: An overview
- Components of blood plasma
- Derivation of various plasma therapeutics
PART 06: Global plasma therapeutics market
- Market overview
- Market size and forecast
PART 07: Plasma fractionation market
- Overview
- Market size and forecast
- Market players
PART 08: Albumin: An overview
- Types of albumin
- Albumin in human body
- Clinical uses
PART 09: Pipeline portfolio
PART 10: Global albumin market
PART 11: Market landscape
- Global human albumin market
- Five forces analysis
PART 12: Market segmentation by application
- Replacement therapy
- Drug formulation and delivery
- Vaccine ingredients
- Others
PART 13: Geographical segmentation
- Global human albumin market by geographical segmentation 2015-2020
- Human albumin market in APAC
- Human albumin market in Americas
- Human albumin market in EMEA
PART 14: China albumin market
- Plasma therapeutics market in China
- Human albumin market in China
PART 15: Market drivers
- High demand for human albumin in China
- Exploitation of new therapeutic indications
- Increase in production capacity
PART 16: Impact of drivers
PART 17: Market challenges
- High cost of therapy
- Spread of pathogenic contaminants
- High regulations in the market
Continue……
For more information or any query mail at sales@wiseguyreports.com
About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.